BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17329249)

  • 21. Characteristics of the Ca2+ spike and oscillations induced by different doses of thyrotropin-releasing hormone (TRH) in individual pituitary cells and nonexcitable cells transfected with TRH receptor complementary deoxyribonucleic acid.
    Nelson EJ; Hinkle PM
    Endocrinology; 1994 Sep; 135(3):1084-92. PubMed ID: 8070350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The third intracellular loop of the human somatostatin receptor 5 is crucial for arrestin binding and receptor internalization after somatostatin stimulation.
    Peverelli E; Mantovani G; Calebiro D; Doni A; Bondioni S; Lania A; Beck-Peccoz P; Spada A
    Mol Endocrinol; 2008 Mar; 22(3):676-88. PubMed ID: 18096696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the C-terminal tail of the rat thyrotropin-releasing hormone receptor-1 in interactions and cointernalization with beta-arrestin 1-green fluorescent protein.
    Groarke DA; Drmota T; Bahia DS; Evans NA; Wilson S; Milligan G
    Mol Pharmacol; 2001 Feb; 59(2):375-85. PubMed ID: 11160875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged stimulation with thyrotropin-releasing hormone and pituitary adenylate cyclase-activating polypeptide desensitize their receptor functions in prolactin-producing GH3 cells.
    Mijiddorj T; Kanasaki H; Unurjargal S; Oride A; Purwana I; Miyazaki K
    Mol Cell Endocrinol; 2013 Jan; 365(2):139-45. PubMed ID: 23103668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real time visualization of agonist-mediated redistribution and internalization of a green fluorescent protein-tagged form of the thyrotropin-releasing hormone receptor.
    Drmota T; Gould GW; Milligan G
    J Biol Chem; 1998 Sep; 273(37):24000-8. PubMed ID: 9727016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A constitutively active mutant thyrotropin-releasing hormone receptor is chronically down-regulated in pituitary cells: evidence using chlordiazepoxide as a negative antagonist.
    Heinflink M; Nussenzveig DR; Grimberg H; Lupu-Meiri M; Oron Y; Gershengorn MC
    Mol Endocrinol; 1995 Nov; 9(11):1455-60. PubMed ID: 8584022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible involvement of thyrotropin-releasing hormone receptor 3 in the release of prolactin in the metamorphosing bullfrog larvae.
    Nakano M; Hasunuma I; Minagawa A; Iwamuro S; Yamamoto K; Kikuyama S; Machida T; Kobayashi T
    Gen Comp Endocrinol; 2018 Oct; 267():36-44. PubMed ID: 29864416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyrotropin-releasing hormone rapidly activates protein phosphorylation in GH3 pituitary cells by a lipid-linked, protein kinase C-mediated pathway.
    Drust DS; Martin TF
    J Biol Chem; 1984 Dec; 259(23):14520-30. PubMed ID: 6238963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NR4A1 (Nur77) mediates thyrotropin-releasing hormone-induced stimulation of transcription of the thyrotropin β gene: analysis of TRH knockout mice.
    Nakajima Y; Yamada M; Taguchi R; Shibusawa N; Ozawa A; Tomaru T; Hashimoto K; Saito T; Tsuchiya T; Okada S; Satoh T; Mori M
    PLoS One; 2012; 7(7):e40437. PubMed ID: 22792320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of hypothyroidism and hypoprolactinemia by growth hormone producing rat pituitary tumors.
    Seo H; Refetoff S; Fang VS
    Endocrinology; 1977 Jan; 100(1):216-26. PubMed ID: 401484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Desensitization, trafficking, and resensitization of the pituitary thyrotropin-releasing hormone receptor.
    Hinkle PM; Gehret AU; Jones BW
    Front Neurosci; 2012; 6():180. PubMed ID: 23248581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1,25-Dihydroxyvitamin D3-induced upregulation of the thyrotropin-releasing hormone receptor in clonal rat pituitary GH3 cells.
    Atley LM; Lefroy N; Wark JD
    J Endocrinol; 1995 Dec; 147(3):397-404. PubMed ID: 8543909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyrotropin-releasing hormone-stimulated [3H]inositol metabolism in GH3 pituitary tumor cells. Studies with lithium.
    Drummond AH; Bushfield M; Macphee CH
    Mol Pharmacol; 1984 Mar; 25(2):201-8. PubMed ID: 6321943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production and characterization of polyclonal anti-idiotypic anti-TRH antibodies: application to the study of pituitary TRH receptor.
    Grouselle D; Roland J; Rousselet A; Denoulet P; Cazenave PA; Tixier-Vidal A; Gourdji D
    Neuroendocrinology; 1994 May; 59(5):495-504. PubMed ID: 8022525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visualizing differences in ligand-induced beta-arrestin-GFP interactions and trafficking between three recently characterized G protein-coupled receptors.
    Evans NA; Groarke DA; Warrack J; Greenwood CJ; Dodgson K; Milligan G; Wilson S
    J Neurochem; 2001 Apr; 77(2):476-85. PubMed ID: 11299310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A receptor-G protein coupling-independent step in the internalization of the thyrotropin-releasing hormone receptor.
    Petrou C; Chen L; Tashjian AH
    J Biol Chem; 1997 Jan; 272(4):2326-33. PubMed ID: 8999941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of extracellular signal-regulated kinase (ERK) and induction of mitogen-activated protein kinase phosphatase 1 (MKP-1) by perifused thyrotropin-releasing hormone (TRH) stimulation in rat pituitary GH3 cells.
    Oride A; Kanasaki H; Mutiara S; Purwana IN; Miyazaki K
    Mol Cell Endocrinol; 2008 Dec; 296(1-2):78-86. PubMed ID: 18824214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Posttranscriptional up-regulation of thyrotropin-releasing hormone (TRH) receptor messenger ribonucleic acid by TRH in COS-1 cells transfected with mouse pituitary TRH receptor complementary deoxyribonucleic acid.
    Fujimoto J; Narayanan CS; Benjamin JE; Gershengorn MC
    Endocrinology; 1992 Oct; 131(4):1716-20. PubMed ID: 1327718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pituitary adenylate cyclase-activating polypeptide regulates prolactin promoter activity via a protein kinase A-mediated pathway that is independent of the transcriptional pathway employed by thyrotropin-releasing hormone.
    Coleman DT; Chen X; Sassaroli M; Bancroft C
    Endocrinology; 1996 Apr; 137(4):1276-85. PubMed ID: 8625900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential regulatory roles for G protein-coupled receptor kinases and beta-arrestins in gonadotropin-releasing hormone receptor signaling.
    Neill JD; Duck LW; Musgrove LC; Sellers JC
    Endocrinology; 1998 Apr; 139(4):1781-8. PubMed ID: 9528962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.